Home > News > Bilcare buys Singapore's Singular ID for S$20m
January 4th, 2008
Bilcare buys Singapore's Singular ID for S$20m
Abstract:
Bilcare has acquired Singapore-based Singular ID for 20 million Singapore dollars, reports CNBC-TV18. The latter provides pharma counterfeit solutions.
Bilcare has been looking at advancing its technology, in terms of solutions for counterfeit drugs. Now, it has gone ahead and acquired a Singapore-based company called Singular ID. They had been looking at this particular company for sometime.
Singular ID is a very high technology company, which uses nanotechnology, in terms of developing solutions to minimize the use of counterfeit drugs, which is seen as a big menace for most of the pharmaceutical companies.
Source:
moneycontrol.com
Related News Press |
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
New chip ramps up AI computing efficiency August 19th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||